Associated Papers
Trans-activating mutations of the pseudokinase ERBB3.
Koivu MKA et al.
Oncogene, 2024
38806620 (PubMed )
Supplement: 41388_2024_3070_MOESM3_ESM.xlsx › Processed_PacBio_data
ERBB3 mutations in cancer: biological aspects, prevalence and therapeutics.
Kiavue N et al.
Oncogene, 2020
The prognostic effects of somatic mutations in ER-positive breast cancer.
Griffith OL et al.
Nature Communications, 2018
Select a paper to view details